REG - Tristel PLC - Confirmation of CFO Appointment

TristelAnnouncement

Mon 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250901:nRSA2969Xa&default-theme=true

RNS Number : 2969X  Tristel PLC  01 September 2025

TRISTEL plc

("Tristel" or the "Company")

 

Confirmation of CFO Appointment

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products,
confirms the appointment of Anna Wasyl as Chief Financial Officer ("CFO") of
Tristel, effective from today.

 

As previously announced in July 2025
(https://www.londonstockexchange.com/news-article/TSTL/appointment-of-chief-financial-officer/17138429)
, Anna joins the Company replacing Liz Dixon who left the business on 30 June
2025, having been with the Group since 2007. Anna brings extensive experience
from her previous roles across different sectors including medical devices,
robotics, and industrial automation. She has over 20 years of experience
across publicly listed and venture-backed companies and joins from CMR
Surgical, the Cambridge-based global surgical robotics business, where she
served as Chief Commercial Partnerships and Operations Officer, having
previously held the role of Group CFO.

 

 

Anna Wasyl, Chief Financial Officer of Tristel plc

 

Matt Sassone, CEO of Tristel plc, said: "Anna has joined at an exciting time
for Tristel plc. We welcome Anna to the Tristel team and look forward to
updating the market on the Company's progress at the preliminary results in
October."

 

For further information please contact:

 Tristel plc                                                                Via Walbrook PR
 Matt Sassone, Chief Executive Officer                                      www.investors.tristel.com (http://www.investors.tristel.com/)
 Anna Wasyl, Chief Financial Officer

 Walbrook PR Ltd                                                            Tel: 020 7933 8780 or tristel@walbrookpr.com
 Paul McManus / Lianne Applegarth / Anna Dunphy    Mob: 07980 541 893/ 07584 391 303/ 07876 741 001

 Cavendish Capital Markets Ltd                                              Tel: 020 7220 0500
 Geoff Nash / Callum Davidson/Trisyia Jamaludin (Corporate Finance)
 Sunila de Silva (Corporate Broking) / Louise Talbot (Sales)

 

 

About Tristel plc

Tristel plc is a global infection prevention company focussed on the
manufacture and supply of products using its unique proprietary chlorine
dioxide (ClO(2)) chemistry. The Company is a market leader in manual
decontamination of medical devices, supplying hospitals under the Tristel
(https://tristel.com/) brand, and under the Cache
(https://thecachecollection.com/) brand provides products for sporicidal
surface disinfection, a more sustainable alternative to commonly used
pre-wetted plastic wipes.

 

Tristel's head office and manufacturing facility is located in Snailwell, near
Cambridge, and operates globally employing approximately 270 people across 16
subsidiaries selling into 40+ countries. The Company targets annual revenue
growth of between 10% and 15% and an EBITDA margin of at least 25% and the
business is profitable, with no debt and has a progressive dividend policy.

 

The Company has been listed on the London Stock Exchange's AIM market since
2005 (AIM: TSTL).

 

For more information about Tristel's product range please visit:
https://tristel.com (https://tristel.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAPKCBDNBKDAFB